Explore more publications!
Health Times Virgin Islands
Submit Press Release

Health Times Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times Virgin Islands.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 10, 2025

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
October 10, 2025

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025

Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million
October 10, 2025

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million

Indeterminate GlobeNewswire
FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
October 10, 2025

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Indeterminate GlobeNewswire
RTOERO awards $104,000 in grants to boost local projects
October 10, 2025

RTOERO awards $104,000 in grants to boost local projects

Indeterminate GlobeNewswire
Ergodyne Unveils New Winter Gear to Help Outdoor Workers Outlast Harsh Conditions
October 10, 2025

Ergodyne Unveils New Winter Gear to Help Outdoor Workers Outlast Harsh Conditions

Indeterminate GlobeNewswire
AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
October 10, 2025

AB Science today reports its revenues for the first half of 2025 and provides an update on its activities

Indeterminate GlobeNewswire
AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2025 et présente un point sur ses activités
October 10, 2025

AB Science annonce aujourd’hui ses résultats financiers semestriels au 30 juin 2025 et présente un point sur ses activités

Indeterminate GlobeNewswire
Dua Lipa, Drag Icons, Diplo and Celebrities Headline MISTR’s National PrEP Day Kickoff
October 10, 2025

Dua Lipa, Drag Icons, Diplo and Celebrities Headline MISTR’s National PrEP Day Kickoff

Indeterminate GlobeNewswire
Priovant’s Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch
October 10, 2025

Priovant’s Brepocitinib Poised to Address Steroid-Sparing Gap in Dermatomyositis as Rheumatologists Anticipate 2026 Launch

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million
October 10, 2025

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million

Indeterminate GlobeNewswire
Zacks Small-Cap Research Initiates Coverage on NewGen
October 10, 2025

Zacks Small-Cap Research Initiates Coverage on NewGen

Indeterminate GlobeNewswire
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance
October 10, 2025

WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance

Indeterminate GlobeNewswire
Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility
October 10, 2025

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Indeterminate GlobeNewswire
Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025
October 10, 2025

Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025

Indeterminate GlobeNewswire
Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe
October 10, 2025

Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe

Indeterminate GlobeNewswire
Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit
October 10, 2025

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

Indeterminate GlobeNewswire
Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025
October 10, 2025

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions